Cargando…

Immunogenic Cell Death (ICD)-Related Gene Signature Could Predict the Prognosis of Patients with Diffuse Large B-Cell Lymphoma

Background: Diffuse large B-cell lymphoma (DLBCL) is the most prevalent type of lymphoma that is potentially curable by chemotherapy. Immunogenic cell death (ICD) is regarded as an essential process for the clearance of residual tumor cells. However, the impact of ICD on DLBCL remains unknown. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ping, Liqin, He, Yanxia, Gao, Yan, Wang, Xiaoxiao, Huang, Cheng, Bai, Bing, Huang, Huiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696383/ https://www.ncbi.nlm.nih.gov/pubmed/36579538 http://dx.doi.org/10.3390/jpm12111840

Ejemplares similares

Systematic Oxidative Stress Indexes Associated with the Prognosis in Patients with T Lymphoblastic Lymphoma/Leukemia
por: Ping, Liqin, et al.
Publicado: (2022)

A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma
por: Zhang, Jianhua, et al.
Publicado: (2023)

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
por: Zhang, Pengpeng, et al.
Publicado: (2023)

PB1733: LONG-TERM FOLLOW-UP FOR PATIENTS WITH T CELL LYMPHOBLASTIC LYMPHOMA/ ACUTE LYMPHOBLASTIC LEUKEMIA WHO RECEIVED MODIFIED BFM PROTOCOLS
por: Gao, Yan, et al.
Publicado: (2023)

Natural Melanin-Based Nanoparticles With Combined Chemo/Photothermal/Photodynamic Effect Induce Immunogenic Cell Death (ICD) on Tumor
por: Liu, Ding, et al.
Publicado: (2021)

Association of circulating tumor DNA from the cerebrospinal fluid with high‐risk CNS involvement in patients with diffuse large B‐cell lymphoma
por: Wang, Xiaoxiao, et al.
Publicado: (2021)

Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction
por: Mardi, Amirhossein, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
por: Wang, Chenxing, et al.
Publicado: (2022)

Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy
por: Sansone, Clementina, et al.
Publicado: (2021)

Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma
por: Hu, Yuanyuan, et al.
Publicado: (2022)

An Autophagy-Related Gene Signature can Better Predict Prognosis and Resistance in Diffuse Large B-Cell Lymphoma
por: Zhou, Xuan, et al.
Publicado: (2022)

Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
por: Kang, Zhen, et al.
Publicado: (2023)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity
por: Jiang, Shan, et al.
Publicado: (2023)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
por: Cui, Yingshu, et al.
Publicado: (2023)

R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma
por: Mishima, Yuko, et al.
Publicado: (2012)

Identification of immunogenic cell death‑related prognostic signatures in pancreatic cancer
por: Yu, Wenjing, et al.
Publicado: (2023)

The PTEN tumor suppressor gene and its role in lymphoma pathogenesis
por: Wang, Xiaoxiao, et al.
Publicado: (2015)

Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem
por: Ren, Junjie, et al.
Publicado: (2021)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
por: Dong, Bingqi, et al.
Publicado: (2023)

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma
por: Zhang, Chaofeng, et al.
Publicado: (2023)

High Serum Level of Soluble Programmed Death Ligand 1 is Associated With a Poor Prognosis in Hodgkin Lymphoma
por: Guo, Xiaofang, et al.
Publicado: (2018)

Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
por: Liu, Guohao, et al.
Publicado: (2022)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma
por: Nan, Ying-Yu, et al.
Publicado: (2021)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

A glycolysis-related gene signatures in diffuse large B-Cell lymphoma predicts prognosis and tumor immune microenvironment
por: Cui, Yingying, et al.
Publicado: (2023)

PB2129: COULD LYMPHOPENIA PREDICT OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA?
por: Merchan Muñoz, B., et al.
Publicado: (2022)

Hypoxic Wharton's Jelly Stem Cell Conditioned Medium Induces Immunogenic Cell Death in Lymphoma Cells
por: Lin, Hao Daniel, et al.
Publicado: (2020)

Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
por: Feng, Pengcheng, et al.
Publicado: (2021)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
por: Sun, Zhiqiang, et al.
Publicado: (2022)

Construction of immunogenic cell death-related molecular subtypes and prognostic signature in colorectal cancer
por: Yu, Chun, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analyses of Immunogenic Cell Death as a Biomarker in Predicting Prognosis and Therapeutic Response
por: Wang, Yuan, et al.
Publicado: (2022)

The clinical features and prognosis of 31 HIV-infected diffuse large B-cell lymphoma cases
por: Lian, Yun, et al.
Publicado: (2021)

Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma
por: Plaça, Jessica Rodrigues, et al.
Publicado: (2022)

Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
por: Thudium Mueller, Karen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lttf7r9ta4bg7sj3nbhjmm9vjh